FDA NDC Directory · JSON-LD · Markdown

ADCETRIS

NDC 51144-050 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic namebrentuximab vedotin
Labeler / ManufacturerSEAGEN INC.
Marketing categoryBiologic License Application · App BLA125388
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsBRENTUXIMAB VEDOTIN (50 mg/10.5mL)
Marketing started20110825
Package count1

External sources

Source: openFDA. Public-domain (CC0).